Close

Dipexium Pharma (DPRX) Announces Locilex Phase 3s Missed Primary Endpoints

October 25, 2016 7:04 AM EDT Send to a Friend
Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX) announced that the OneStep-1 and OneStep-2 Phase 3 clinical trials of Locilex (pexiganan cream 0.8%) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login